CADX Financial Facts
Amortization of patent license: 335KProduct revenue, net: 33.29M
See Full Income Statement
Investments in marketable securities: -6.09M
Total current assets: 77.89M
See Full Balance Sheet
Cadence Pharma (CADX) Earnings
|
Expand Research on CADX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -26.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/28/14 | Q413 | -$0.05 | -$0.04 | -$0.01 | $33.3M | $32.51M | N/A |  | | Details | |
| 3/7/13 | Q412 | -$0.25 | -$0.16 | -$0.09 | $17.1M | $16.74M | N/A | | | Details | |
11/5/12  |
Q312 | -$0.19 | -$0.19 | $0.00 | $13.9M | $14.16M | N/A | | | Details | |
| 5/3/12 | Q112 | -$0.27 | -$0.22 | -$0.05 | $8M | $8.93M | = | | | Details | |
| 3/12/12 | Q411 | -$0.28 | -$0.27 | -$0.01 | $5.9M | $6.88M | N/A | | | Details | |
| 11/3/11 |
 |
Q311 | -$0.34 | -$0.36 | +$0.02 | N/A | $4.17M | N/A | | | Details |
| 8/3/11 |
Q211 | -$0.30 | -$0.38 | +$0.08 | $1.7M | $1.62M | N/A | | | Details | |
| 5/5/11 |
|
Q111 | N/A | -$0.33 | N/A | N/A | $710K | N/A | N/A | N/A |
